SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-007843
Filing Date
2020-05-06
Accepted
2020-05-06 17:02:16
Documents
6
Period of Report
2020-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33995
2 ex10-1.htm EX-10.1 3588
3 ex10-1_001.jpg GRAPHIC 406173
4 ex10-1_002.jpg GRAPHIC 419894
5 ex10-1_003.jpg GRAPHIC 434368
6 ex10-1_004.jpg GRAPHIC 104860
  Complete submission text file 0001493152-20-007843.txt   1919722
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 20853460
SIC: 2834 Pharmaceutical Preparations